BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11340340)

  • 1. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
    Calvo N; Volosin M
    Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors.
    Bitran D; Shiekh M; Dowd JA; Dugan MM; Renda P
    Pharmacol Biochem Behav; 1998 Aug; 60(4):879-87. PubMed ID: 9700972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze.
    Korte SM; de Boer SF; de Kloet ER; Bohus B
    Psychoneuroendocrinology; 1995; 20(4):385-94. PubMed ID: 8532822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats.
    Smythe JW; Murphy D; Timothy C; Costall B
    Pharmacol Biochem Behav; 1997 Mar; 56(3):507-13. PubMed ID: 9077590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress.
    Calvo N; Martijena ID; Molina VA; Volosin M
    Brain Res; 1998 Aug; 800(2):227-35. PubMed ID: 9685654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
    Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
    Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety.
    Korte SM; Korte-Bouws GA; Koob GF; De Kloet ER; Bohus B
    Pharmacol Biochem Behav; 1996 May; 54(1):261-7. PubMed ID: 8728567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies.
    Kim PJ; Cole MA; Kalman BA; Spencer RL
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):213-22. PubMed ID: 9879980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat.
    Morano MI; Vázquez DM; Akil H
    Mol Cell Neurosci; 1994 Oct; 5(5):400-12. PubMed ID: 7820364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors.
    Oitzl MS; Fluttert M; de Kloet ER
    Eur J Neurosci; 1994 Jul; 6(7):1072-9. PubMed ID: 7952288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of hippocampal theta activity by corticosterone: opposing functions of mineralocorticoid and glucocorticoid receptors.
    Murphy D; Costall B; Smythe JW
    Brain Res Bull; 1998 Apr; 45(6):631-5. PubMed ID: 9566508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids.
    Tanaka J; Fujita H; Matsuda S; Toku K; Sakanaka M; Maeda N
    Glia; 1997 May; 20(1):23-37. PubMed ID: 9145302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of angiotensin II-induced drinking by glucocorticoids is a specific glucocorticoid type II receptor (GR)-mediated event.
    Sumners C; Gault TR; Fregly MJ
    Brain Res; 1991 Jun; 552(2):283-90. PubMed ID: 1913190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus.
    van Haarst AD; Oitzl MS; de Kloet ER
    Neurochem Res; 1997 Nov; 22(11):1323-8. PubMed ID: 9355104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats.
    Oitzl MS; Fluttert M; Sutanto W; de Kloet ER
    Eur J Neurosci; 1998 Dec; 10(12):3759-66. PubMed ID: 9875354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory vs. inhibitory effects of acute stress on plasma LH: differential effects of pretreatment with dexamethasone or the steroid receptor antagonist, RU 486.
    Briski KP
    Pharmacol Biochem Behav; 1996 Sep; 55(1):19-26. PubMed ID: 8870033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides.
    Reul JM; Probst JC; Skutella T; Hirschmann M; Stec IS; Montkowski A; Landgraf R; Holsboer F
    Neuroendocrinology; 1997 Mar; 65(3):189-99. PubMed ID: 9088000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.